T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS

Markets PR Newswire By PR Newswire 17 Sep 2026 13:58 1 min read
T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS

Continuing steady expansion of its ETF lineup, the firm adds three new active equity offerings BALTIMORE, Sept. 17, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of three new equity exchange traded funds...

Covered in this story

What has happened since

  • T. Rowe Price is down 0.7% since this was published, 33 days ago.

Price move measured from the close nearest publication to the latest quote.

Analyst targets on T. Rowe Price

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $TROW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on T. Rowe Price →
Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.